Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance

Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance

Abstract Recent breakthroughs in targeted therapy and immunotherapy have revolutionized the treatment of lung cancer, the leading cause of cancer-related deaths in the United States and worldwide. Here we provide an overview of recent progress in immune checkpoint blockade therapy for treatment of n...

Full description

Bibliographic Details
Main Authors: Xingxiang Pu, Lin Wu, Dan Su, Weimin Mao, Bingliang Fang
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cancer
Subjects:
Immune checkpoint inhibitors
PD-1
PD-L1
Predictive biomarkers
Resistance
Online Access:http://link.springer.com/article/10.1186/s12885-018-4990-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4990-5

Similar Items